Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.
about
Predictive Performance of a Vancomycin Population Pharmacokinetic Model in NeonatesCoagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.Using a vancomycin PBPK model in special populations to elucidate case-based clinical PK observations.
P2860
Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Vancomycin pharmacokinetic mod ...... esistant bacterial infections.
@en
type
label
Vancomycin pharmacokinetic mod ...... esistant bacterial infections.
@en
prefLabel
Vancomycin pharmacokinetic mod ...... esistant bacterial infections.
@en
P2093
P2860
P1476
Vancomycin pharmacokinetic mod ...... resistant bacterial infections
@en
P2093
Catherijne A J Knibbe
Jessica K Roberts
Jonathan E Constance
Michael G Spigarelli
P2860
P304
P356
10.1586/14787210.2014.966081
P577
2014-11-01T00:00:00Z